Citations (58)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Abdullah S. Shatoor, Suliman Al Humayed, Mahmoud A. Alkhateeb, Khalid A. Shatoor, Hussain Aldera, Mohammed Alassiri & Ali A. Shati. (2019) Crataegus Aronia protects and reverses vascular inflammation in a high fat diet rat model by an antioxidant mechanism and modulating serum levels of oxidized low-density lipoprotein. Pharmaceutical Biology 57:1, pages 37-47.
Read now
Read now
Mohammad Hassan Nemati & Behrooz Astaneh. (2010) Optimal management of familial hypercholesterolemia: treatment and management strategies. Vascular Health and Risk Management 6, pages 1079-1088.
Read now
Read now
Trond Leren. (2009) Comparison of clinical and molecular genetic criteria for diagnosing familial hypercholesterolemia. Clinical Lipidology 4:3, pages 303-310.
Read now
Read now
Kavita Kalidas & Réza Behrouz. (2008) Inherited metabolic disorders and cerebral infarction. Expert Review of Neurotherapeutics 8:11, pages 1731-1741.
Read now
Read now
Articles from other publishers (54)
Maria Cristina de Oliveira Izar, Viviane Zorzanelli Rocha Giraldez, Adriana Bertolami, Raul Dias dos SantosFilhoFilho, Ana Maria Lottenberg, Marcelo Heitor Vieira Assad, José Francisco Kerr Saraiva, Ana Paula M. Chacra, Tania L. R. Martinez, Luciana Ribeiro Bahia, Francisco Antonio Helfenstein Fonseca, Andre Arpad Faludi, Andrei C. Sposito, Antônio Carlos Palandri Chagas, Cinthia Elim Jannes, Cristiane Kovacs Amaral, Daniel Branco de Araújo, Dennys Esper Cintra, Elaine dos Reis Coutinho, Fernando Cesena, Hermes Toros Xavier, Isabela Cardoso Pimentel Mota, Isabela de Carlos Back Giuliano, José Rocha FariaNetoNeto, Juliana Tieko Kato, Marcelo Chiara Bertolami, Marcio Hiroshi Miname, Maria Helane Costa Gurgel Castelo, Maria Sílvia Ferrari Lavrador, Roberta Marcondes Machado, Patrícia Guedes de Souza, Renato Jorge Alves, Valeria Arruda Machado & Wilson SalgadoFilhoFilho. (2021) Atualização da Diretriz Brasileira de Hipercolesterolemia Familiar – 2021. Arquivos Brasileiros de Cardiologia.
Crossref
Crossref
Jean Ferrières, Victoria Banks, Demetris Pillas, Francesco Giorgianni, Laurene Gantzer, Beranger Lekens, Lea Ricci, Margaux Dova-Boivin, Jean-Vannak Chauny, Guillermo Villa & Gaelle Désaméricq. (2021) Screening and treatment of familial hypercholesterolemia in a French sample of ambulatory care patients: A retrospective longitudinal cohort study. PLOS ONE 16:8, pages e0255345.
Crossref
Crossref
Behrooz Astaneh, Nima Makhdami, Vala Astaneh & Gordon Guyatt. (2021) The Effect of Mipomersen in the Management of Patients with Familial Hypercholesterolemia: A Systematic Review and Meta-Analysis of Clinical Trials. Journal of Cardiovascular Development and Disease 8:7, pages 82.
Crossref
Crossref
Roeland HuijgenDirk J. Blom, Merel L. HartgersKévin ChemelloAsier Benito-Vicente, Kepa B. UribeZorena BehardienDee M. Blackhurst, Brigitte C. BriceJoep C. DefescheAnnemiek G. de JongRosemary J. JoosteGabriele A.E. SolomonKaren H. WolmaransG. Kees Hovingh, Cesar Martin, Gilles LambertA. David Marais. (2021) Novel PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Variants in Patients With Familial Hypercholesterolemia From Cape Town. Arteriosclerosis, Thrombosis, and Vascular Biology 41:2, pages 934-943.
Crossref
Crossref
A. J. Cupido, R. M. Stoekenbroek & J. J. P. Kastelein. 2020. Clinical Cardiogenetics. Clinical Cardiogenetics
387
411
.
Khalid Al-Rasadi, Khalid F. Alhabib, Faisal Al-Allaf, Khalid Al-Waili, Ibrahim Al-Zakwani, Ahmad AlSarraf, Wael Almahmeed, Nasreen AlSayed, Mohammad Alghamdi, Mohammed A. Batais, Turky H. Almigbal, Fahad Alnouri, Abdulhalim Kinsara, Ashraf Hammouda, Zuhier Awan, Heba Kary, Omer A. Elamin, Fahad Zadjali, Mohammed Al-Jarallah, Abdullah Shehab, Hani Sabbour, Haitham Amin & Hani Altaradi. (2019) The Gulf Familial Hypercholesterolemia Registry (Gulf FH): Design, Rationale and Preliminary Results. Current Vascular Pharmacology 18:1, pages 57-64.
Crossref
Crossref
Viktoria Korneva, Tatiana Kuznetsova & Ulrich Julius. (2019) Efficiency and problems of statin therapy in patients with heterozygous familial hypercholesterolemia. Atherosclerosis Supplements 40, pages 79-87.
Crossref
Crossref
V. A. Korneva, T. Yu. Kuznetsova & G. P. Tihova. (2019) Lipid Lowering Therapy with Statins in Patients with Heterozygous Familial Hypercholesterolemia. Kardiologiia 59:3, pages 27-35.
Crossref
Crossref
Xander M. van Delden, Roeland Huijgen, Karen H. Wolmarans, Brigitte C. Brice, Jennifer K. Barron, Dirk J. Blom & A. David Marais. (2018) LDL-cholesterol target achievement in patients with heterozygous familial hypercholesterolemia at Groote Schuur Hospital: Minority at target despite large reductions in LDL-C. Atherosclerosis 277, pages 327-333.
Crossref
Crossref
Ares Pasipoularides. (2018) Implementing genome-driven personalized cardiology in clinical practice. Journal of Molecular and Cellular Cardiology 115, pages 142-157.
Crossref
Crossref
Giancarla Scalone & Giampaolo Niccoli. 2018. Coronary Microvascular Obstruction in Acute Myocardial Infarction. Coronary Microvascular Obstruction in Acute Myocardial Infarction
209
236
.
Quantil M. Melendez, Sreevidhya T. Krishnaji, Catherine J. Wooten & Dayami Lopez. (2017) Hypercholesterolemia: The role of PCSK9. Archives of Biochemistry and Biophysics 625-626, pages 39-53.
Crossref
Crossref
Maya S. Safarova, Hongfang Liu & Iftikhar J. Kullo. (2016) Rapid identification of familial hypercholesterolemia from electronic health records: The SEARCH study. Journal of Clinical Lipidology 10:5, pages 1230-1239.
Crossref
Crossref
Stephanie Maiwald, Mahdi M Motazacker, Julian C van Capelleveen, Suthesh Sivapalaratnam, Allard C van der Wal, Chris van der Loos, John J P Kastelein, Willem H Ouwehand, G Kees Hovingh, Mieke D Trip, Jaap D van Buul & Geesje M Dallinga-Thie. (2015) A rare variant in MCF2L identified using exclusion linkage in a pedigree with premature atherosclerosis. European Journal of Human Genetics 24:1, pages 86-91.
Crossref
Crossref
A. J. Cupido, R. M. Stoekenbroek & J. J. P. Kastelein. 2016. Clinical Cardiogenetics. Clinical Cardiogenetics
331
354
.
Paulo Caleb Junior Lima Santos & Alexandre Costa Pereira. (2015)
Type of
LDLR
mutation and the pharmacogenetics of familial hypercholesterolemia treatment
. Pharmacogenomics 16:15, pages 1743-1750.
Crossref
Crossref
Erik P A van Iperen, Suthesh Sivapalaratnam, S Matthijs Boekholdt, G Kees Hovingh, Stephanie Maiwald, Michael W Tanck, Nicole Soranzo, Jonathan C Stephens, Jennifer G Sambrook, Marcel Levi, Willem H Ouwehand, John JP Kastelein, Mieke D Trip & Aeilko H Zwinderman. (2013) Common genetic variants do not associate with CAD in familial hypercholesterolemia. European Journal of Human Genetics 22:6, pages 809-813.
Crossref
Crossref
Stephanie Maiwald, Suthesh Sivapalaratnam, Mahdi M. Motazacker, Julian C. van Capelleveen, Ilze Bot, Saskia C. de Jager, Miranda van Eck, Jennifer Jolley, Johan Kuiper, Jonathon Stephens, Cornelius A. Albers, C. Ruben Vosmeer, Heleen Kruize, Daan P. Geerke, Allard C. van der Wal, Chris M. van der Loos, John J. P. Kastelein, Mieke D. Trip, Willem H. Ouwehand, Geesje M. Dallinga-Thie & G. Kees Hovingh. (2014) Mutation in KERA Identified by Linkage Analysis and Targeted Resequencing in a Pedigree with Premature Atherosclerosis. PLoS ONE 9:5, pages e98289.
Crossref
Crossref
Paulo Caleb Junior Lima Santos, Aline Cruz Morgan, Cintia Elin Jannes, Luciana Turolla, Jose Eduardo Krieger, Raul D. Santos & Alexandre Costa Pereira. (2014) Presence and type of low density lipoprotein receptor (LDLR) mutation influences the lipid profile and response to lipid-lowering therapy in Brazilian patients with heterozygous familial hypercholesterolemia. Atherosclerosis 233:1, pages 206-210.
Crossref
Crossref
D. M. Kusters, R. Huijgen, J. C. Defesche, M. N. Vissers, I. Kindt, B. A. Hutten & J. J. P. Kastelein. 2014. De Nederlandse gezondheidszorg. De Nederlandse gezondheidszorg
95
102
.
B. G. Nordestgaard, M. J. Chapman, S. E. Humphries, H. N. Ginsberg, L. Masana, O. S. Descamps, O. Wiklund, R. A. Hegele, F. J. Raal, J. C. Defesche, A. Wiegman, R. D. Santos, G. F. Watts, K. G. Parhofer, G. K. Hovingh, P. T. Kovanen, C. Boileau, M. Averna, J. Boren, E. Bruckert, A. L. Catapano, J. A. Kuivenhoven, P. Pajukanta, K. Ray, A. F. H. Stalenhoef, E. Stroes, M.-R. Taskinen & A. Tybjaerg-Hansen. (2013) Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society. European Heart Journal 34:45, pages 3478-3490.
Crossref
Crossref
Michael Davidson. (2013) The Efficacy of Colesevelam HCl in the Treatment of Heterozygous Familial Hypercholesterolemia in Pediatric and Adult Patients. Clinical Therapeutics 35:8, pages 1247-1252.
Crossref
Crossref
Iris Kindt, Roeland Huijgen, Marieke Boekel, Kristiaan J. van der Gaag, Joep C. Defesche, John J. P. Kastelein & Peter de Knijff. (2013) Quality Assessment of the Genetic Test for Familial Hypercholesterolemia in The Netherlands. Cholesterol 2013, pages 1-8.
Crossref
Crossref
Yoo Ri KimKi Hoon Han. (2013) Familial Hypercholesterolemia and the Atherosclerotic Disease. Korean Circulation Journal 43:6, pages 363.
Crossref
Crossref
Sadik H. KassimHui LiPeter BellSuryanarayan SomanathanWilliam LagorFrank JacobsJeffrey BillheimerJames M. WilsonDaniel J. Rader. (2013) Adeno-Associated Virus Serotype 8 Gene Therapy Leads to Significant Lowering of Plasma Cholesterol Levels in Humanized Mouse Models of Homozygous and Heterozygous Familial Hypercholesterolemia. Human Gene Therapy 24:1, pages 19-26.
Crossref
Crossref
Roeland Huijgen, Iris Kindt, Joep C. Defesche & John J.P. Kastelein. (2012) Cardiovascular risk in relation to functionality of sequence variants in the gene coding for the low-density lipoprotein receptor: a study among 29 365 individuals tested for 64 specific low-density lipoprotein-receptor sequence variants. European Heart Journal 33:18, pages 2325-2330.
Crossref
Crossref
Roeland Huijgen, Sietske JM Homsma, Barbara A Hutten, Iris Kindt, Maud N Vissers, John JP Kastelein & Jan LA van Rijckevorsel. (2012) Improved access to life insurance after genetic diagnosis of familial hypercholesterolaemia: cross-sectional postal questionnaire study. European Journal of Human Genetics 20:7, pages 722-728.
Crossref
Crossref
E. Jarauta, R. Mateo-Gallego, R. Gilabert, N. Plana, M. Junyent, E. de Groot, A. Cenarro, L. Masana, E. Ros & F. Civeira. (2012) Carotid atherosclerosis and lipoprotein particle subclasses in familial hypercholesterolaemia and familial combined hyperlipidaemia. Nutrition, Metabolism and Cardiovascular Diseases 22:7, pages 591-597.
Crossref
Crossref
Roeland HuijgenBarbara A. HuttenIris KindtMaud N. VissersJohn J.P. Kastelein. (2012) Discriminative Ability of LDL-Cholesterol to Identify Patients With Familial Hypercholesterolemia. Circulation: Cardiovascular Genetics 5:3, pages 354-359.
Crossref
Crossref
Mohammad Mahdi Motazacker, James Pirruccello, Roeland Huijgen, Ron Do, Stacey Gabriel, Jorge Peter, Jan Albert Kuivenhoven, Joep C. Defesche, John J.P. Kastelein, G. Kees Hovingh, Noam Zelcer, Sekar Kathiresan & Sigrid W. Fouchier. (2012) Advances in genetics show the need for extending screening strategies for autosomal dominant hypercholesterolaemia. European Heart Journal 33:11, pages 1360-1366.
Crossref
Crossref
R. Huijgen, S.W. Fouchier, M. Denoun, B.A. Hutten, M.N. Vissers, G. Lambert & J.J.P. Kastelein. (2012) Plasma levels of PCSK9 and phenotypic variability in familial hypercholesterolemia. Journal of Lipid Research 53:5, pages 979-983.
Crossref
Crossref
Paulo Caleb Junior Lima Santos, Ana Carolina Moron Gagliardi, Márcio Hiroshi Miname, Ana Paula Chacra, Raul Dias Santos, Jose Eduardo Krieger & Alexandre Costa Pereira. (2011) SLCO1B1 haplotypes are not associated with atorvastatin-induced myalgia in Brazilian patients with familial hypercholesterolemia. European Journal of Clinical Pharmacology 68:3, pages 273-279.
Crossref
Crossref
R Huijgen, ADM Stork, JC Defesche, J Peter, R Alonso, A Cuevas, JJP Kastelein, M Duran & ESG Stroes. (2011) Extreme xanthomatosis in patients with both familial hypercholesterolemia and cerebrotendinous xanthomatosis. Clinical Genetics 81:1, pages 24-28.
Crossref
Crossref
Roeland HuijgenMaud N. VissersIris KindtMieke D. TripEric de GrootJohn J.P. KasteleinBarbara A. Hutten. (2011) Assessment of Carotid Atherosclerosis in Normocholesterolemic Individuals With Proven Mutations in the Low-Density Lipoprotein Receptor or Apolipoprotein B Genes. Circulation: Cardiovascular Genetics 4:4, pages 413-417.
Crossref
Crossref
Cesare Indiveri, Vito Iacobazzi, Annamaria Tonazzi, Nicola Giangregorio, Vittoria Infantino, Paolo Convertini, Lara Console & Ferdinando Palmieri. (2011) The mitochondrial carnitine/acylcarnitine carrier: Function, structure and physiopathology. Molecular Aspects of Medicine 32:4-6, pages 223-233.
Crossref
Crossref
S. Sivapalaratnam, M. M. Motazacker, S. Maiwald, G. K. Hovingh, J. J. P. Kastelein, M. Levi, M. D. Trip & G. M. Dallinga-Thie. (2011) Genome-Wide Association Studies in Atherosclerosis. Current Atherosclerosis Reports 13:3, pages 225-232.
Crossref
Crossref
D. M. Kusters, R. Huijgen, J. C. Defesche, M. N. Vissers, I. Kindt, B. A. Hutten & J. J. P. Kastelein. (2011) Founder mutations in the Netherlands: geographical distribution of the most prevalent mutations in the low-density lipoprotein receptor and apolipoprotein B genes. Netherlands Heart Journal 19:4, pages 175-182.
Crossref
Crossref
Trond P. Leren & Knut Erik Berge. (2011) Subjects with Molecularly Defined Familial Hypercholesterolemia or Familial Defective apoB-100 Are Not Being Adequately Treated. PLoS ONE 6:2, pages e16721.
Crossref
Crossref
A. Bakker, L. Jakulj & J. J. P. Kastelein. 2011. Clinical Cardiogenetics. Clinical Cardiogenetics
305
330
.
Alfredo Halpern, Marcio C Mancini, Maria Eliane C Magalhães, Mauro Fisberg, Rosana Radominski, Marcelo C Bertolami, Adriana Bertolami, Maria Edna de Melo, Maria Teresa Zanella, Marcia S Queiroz & Marcia Nery. (2010) Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment. Diabetology & Metabolic Syndrome 2:1.
Crossref
Crossref
Phoebe A Stapleton, Adam G Goodwill, Milinda E James, Robert W Brock & Jefferson C Frisbee. (2010) Hypercholesterolemia and microvascular dysfunction: interventional strategies. Journal of Inflammation 7:1.
Crossref
Crossref
S. Sivapalaratnam, L.L. van Loendersloot, B.A. Hutten, J.J.P. Kastelein, M.D. Trip & E. de Groot. (2010) Long-term LDL-c lowering in heterozygous familial hypercholesterolemia normalizes carotid intima-media thickness. Atherosclerosis 212:2, pages 571-574.
Crossref
Crossref
Menno VergeerRong ZhouMichiel L. BotsRaphaël DuivenvoordenJoerg KoglinFatima AkdimYale B. MitchelRoeland HuijgenAditi SapreEric de GrootEric J.G. SijbrandsRichard C. PasternakClaude GagnéA. David MaraisChristie M. BallantyneJonathan L. IsaacsohnAnton F. StalenhoefJohn J.P. Kastelein. (2010) Carotid Atherosclerosis Progression in Familial Hypercholesterolemia Patients. Circulation: Cardiovascular Imaging 3:4, pages 398-404.
Crossref
Crossref
Roeland Huijgen, Iris Kindt, Sigrid W. Fouchier, Joep C. Defesche, Barbara A. Hutten, John J.P. Kastelein & Maud N. Vissers. (2010) Functionality of sequence variants in the genes coding for the low-density lipoprotein receptor and apolipoprotein B in individuals with inherited hypercholesterolemia. Human Mutation 31:6, pages 752-760.
Crossref
Crossref
Roeland Huijgen, Evertine J. Abbink, Eric Bruckert, Anton F.H. Stalenhoef, Ben P.M. Imholz, Paul N. Durrington, M.D. Trip, Mats Eriksson, Frank L.J. Visseren, Juergen R. Schaefer & John J.P. Kastelein. (2010) Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: A 12-week, multicenter, randomized, double-blind, controlled trial. Clinical Therapeutics 32:4, pages 615-625.
Crossref
Crossref
Partha Pratim Chakraborty, Sagnik Mukhopadhyay, Arun Achar, Mallika Pal & Prabodh Chandra Mondal. (2010) Migratory polyarthritis in familial hypercholesterolemia (type IIa hyperlipoproteinemia). The Indian Journal of Pediatrics 77:3, pages 329-331.
Crossref
Crossref
Roeland Huijgen, Iris Kindt, Sjoerd B. J. Verhoeven, Eric J. G. Sijbrands, Maud N. Vissers, John J. P. Kastelein & Barbara A. Hutten. (2010) Two Years after Molecular Diagnosis of Familial Hypercholesterolemia: Majority on Cholesterol-Lowering Treatment but a Minority Reaches Treatment Goal. PLoS ONE 5:2, pages e9220.
Crossref
Crossref
Robert S. Holzman, Thomas J. Mancuso, Navil F. Sethna & James A. DiNardoRobert S. Holzman, Thomas J. Mancuso, Navil F. Sethna & James A. DiNardo. 2010. Pediatric Anesthesiology Review. Pediatric Anesthesiology Review
377
386
.
Vito Iacobazzi, Paolo Convertini, Vittoria Infantino, Pasquale Scarcia, Simona Todisco & Ferdinando Palmieri. (2009) Statins, fibrates and retinoic acid upregulate mitochondrial acylcarnitine carrier gene expression. Biochemical and Biophysical Research Communications 388:4, pages 643-647.
Crossref
Crossref
Jamie Cameron, Øystein L. Holla, Mari Ann Kulseth, Trond P. Leren & Knut Erik Berge. (2009) Splice-site mutation c.313+1, G>A in intron 3 of the LDL receptor gene results in transcripts with skipping of exon 3 and inclusion of intron 3. Clinica Chimica Acta 403:1-2, pages 131-135.
Crossref
Crossref
John D. Baxter & Paul Webb. (2009) Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes. Nature Reviews Drug Discovery 8:4, pages 308-320.
Crossref
Crossref
Øystein L. Holla, Sigve Nakken, Morten Mattingsdal, Trine Ranheim, Knut Erik Berge, Joep C. Defesche & Trond P. Leren. (2009) Effects of intronic mutations in the LDLR gene on pre-mRNA splicing: Comparison of wet-lab and bioinformatics analyses. Molecular Genetics and Metabolism 96:4, pages 245-252.
Crossref
Crossref
Tineke M. Meulenkamp, Aad Tibben, Eline D. Mollema, Irene M. van Langen, Albert Wiegman, Guido M. de Wert, Inez D. de Beaufort, Arthur A.M. Wilde & Ellen M.A. Smets. (2008) Predictive genetic testing for cardiovascular diseases: Impact on carrier children. American Journal of Medical Genetics Part A 146A:24, pages 3136-3146.
Crossref
Crossref
A. Schuchert. (2008) Intima-Media-DickeIntima media thickness. Der Kardiologe 2:4, pages 288-293.
Crossref
Crossref